Tumor ablation is the technology used for destroying the tumor which can be done by using imaging technology to place the needle into the tumor organ. The treatment can be done by using various technologies such as radiofrequency ablation, microwave ablation, cryoablation, and other such technologies. There are various cancers that can be treated by this technology such as lung cancer, liver tumor, prostate cancer, kidney tumor, and other tumors. The increasing incidence of cancer and the rising aging population is the major growth factors for this market. Moreover, high efficacy and safety are majorly contributing to the growth.
The government and healthcare authorities are very much concern for using radio and microtechnology due to the side effects associated with it. Hence, it can hinder the growth of the tumor ablation market. However, the research and development in ablation technology for treating the primary breast cancer and adrenal neoplasm, as well as the improvement in imaging technology will fuel the growth of the market in future. Furthermore, the adoption of minimally invasive therapy will increase the usage of this technology and create a huge opportunity for this market.
Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. The developed healthcare infrastructure and increasing healthcare expenditure make the North American region, a dominating market. in addition, the prevalence of cancer in the US further fuel the growth of the market as advanced ablation technologies is needed for destroying the cancerous cells. Asia Pacific is expected to have the highest CAGR in this market due to the improvement in the healthcare industry and the government support for adopting such technology.
There are many companies which are operating in tumor ablation market such as HealthTronics, Inc, Cortex Technology, Cooper Surgical Inc, AtriCure, Inc., Galil Medical Inc., Endocare, Inc., and Integra LifeSciences Holdings Corporation. The companies are working on the development of innovative technologies. In addition, these players have adopted inorganic growth strategies to remain competitive in the market. For an instance: Galil Medical has signed an agreement in October 2017, for the acquisition of Perseon Corporation.
Research methodology
The market study of tumor ablation market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include
• Financial reports of companies involved in the market
• Authentic Public Databases such as the American Cancer Society, National Cancer Institute, OECD, WHO, and others
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog.
The report is intended for the tumor ablation equipment manufacturer, healthcare providers, investing companies, emerging companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market segmentation
Global Tumor Ablation market is segmented on the basis of regional outlook and following segments:
1. Global Tumor Ablation Market Research and Analysis, By Technology
2. Global Tumor Ablation Market Research and Analysis, By Application
3. Global Tumor Ablation Market Research and Analysis, By End-User
4. Global Tumor Ablation Market Research and Analysis, By Region
THE REPORT COVERS
• Comprehensive research methodology of global tumor ablation
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the
• Global tumor ablation market.
• Insights about market determinants which are stimulating the global tumor ablation
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
Companies Mentioned
1. Adagio Medical, Inc.
2. Afreeze GmbH
3. Alpinion Medical Systems Co., Ltd.
4. Arrinex, Inc.
5. Atricure, Inc.
6. ATS Medical, Inc.
7. Biosig Technologies, Inc.
8. Biotronik, Inc.
9. Boston Scientific Corp.
10. BTG Plc
11. BVM Medical Ltd
12. C2 Therapeutics, Inc.
13. Coopersurgical Inc.
14. Endocare, Inc.
15. Erbe Elektromedizin GmbH
16. Galil Medical Inc
17. Healthtronics, Inc.
18. Icecure Medical Ltd
19. Integra Lifesciences Holdings Corp.
20. Koninklijke Philips N.V
21. Medtronic Plc
22. Medwaves Inc.
23. Sanarus Technologies, Inc.
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH T
RENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763 (UK)
